Write a 100-350 word essay about the enzyme human RPN2. Provide information related to enzyme: i) function, ii) reaction pathways, ii) Location, and iv) diseases. In writing include these four subheadings

### Function
Human RPN2, or ribophorin II, is an integral component of the oligosaccharyltransferase (OST) complex, which is essential for the N-linked glycosylation of proteins. This enzymatic process involves the transfer of an oligosaccharide to asparagine residues on nascent proteins, a modification crucial for protein folding, stability, and function. RPN2, along with RPN1, anchors the OST complex to the rough endoplasmic reticulum (ER) membrane, playing a key role in facilitating the glycosylation process.

### Reaction Pathways
RPN2 operates within the N-linked glycosylation pathway, where it is involved in the transfer of an oligosaccharide from a lipid-linked donor (dolichol) to asparagine residues on polypeptides as they are being synthesized and translocated into the ER. This glycosylation step is vital for the proper folding of proteins, their quality control, and subsequent sorting and transport through the Golgi apparatus. The RPN2 subunit is critical for the OST complex’s enzymatic activity, ensuring that proteins are appropriately glycosylated for their roles within the cell.

### Location
RPN2 is localized in the membrane of the rough endoplasmic reticulum (ER), where it is an integral part of the OST complex. The rough ER is the site of protein synthesis and early post-translational modifications, and RPN2’s role here is crucial for the N-linked glycosylation of newly synthesized proteins. The proximity of the rough ER to ribosomes allows RPN2 to effectively interact with nascent polypeptides, ensuring they are glycosylated as they are synthesized.

### Diseases
Defects in the RPN2 gene have been implicated in disorders related to protein misfolding and glycosylation defects, although specific diseases directly caused by RPN2 mutations are not well-documented. Given its role in N-linked glycosylation, disruptions in RPN2 could contribute to congenital disorders of glycosylation (CDG), leading to symptoms such as developmental delays, neurological impairments, and immune system dysfunctions. Additionally, aberrant expression of RPN2 has been associated with cancer progression, where altered glycosylation patterns contribute to tumor growth and metastasis. Understanding RPN2’s function is critical for diagnosing and developing treatments for these conditions.